AIMS/HYPOTHESIS: Increased expression and activity of the lipogenic pathways in adipose tissue may contribute to the development of obesity. As a central enzyme in lipogenesis, the gene encoding fatty acid synthase (FASN) was identified as a candidate gene for determining body fat. In the present study we tested the hypothesis that increased FASN expression links metabolic alterations of excess energy intake, including hyperinsulinaemia, dyslipidaemia and altered adipokine profile to increased body fat mass. SUBJECTS AND METHODS: In paired samples of visceral and subcutaneous adipose tissue from 196 participants (lean or obese), we investigated whether FASN mRNA expression (assessed by PCR) in adipose tissue is increased in obesity and related to visceral fat accumulation, measures of insulin sensitivity (euglycaemic-hyperinsulinaemic clamp) and glucose metabolism. RESULTS: FASN mRNA expression was increased by 1.7-fold in visceral vs subcutaneous fat. Visceral adipose tissue FASN expression was correlated with FASN protein levels, subcutaneous FASN expression, visceral fat area, fasting plasma insulin, serum concentrations of IL-6, leptin and retinol-binding protein 4 (RBP4), and inversely with measures of insulin sensitivity, independently of age, sex and BMI. Moreover, we found significant correlations between FASN expression and markers of renal function, including serum creatinine and urinary albumin excretion. CONCLUSIONS/ INTERPRETATION: Increased FASN gene expression in adipose tissue is linked to visceral fat accumulation, impaired insulin sensitivity, increased circulating fasting insulin, IL-6, leptin and RBP4, suggesting an important role of lipogenic pathways in the causal relationship between consequences of excess energy intake and the development of obesity and type 2 diabetes.
AIMS/HYPOTHESIS: Increased expression and activity of the lipogenic pathways in adipose tissue may contribute to the development of obesity. As a central enzyme in lipogenesis, the gene encoding fatty acid synthase (FASN) was identified as a candidate gene for determining body fat. In the present study we tested the hypothesis that increased FASN expression links metabolic alterations of excess energy intake, including hyperinsulinaemia, dyslipidaemia and altered adipokine profile to increased body fat mass. SUBJECTS AND METHODS: In paired samples of visceral and subcutaneous adipose tissue from 196 participants (lean or obese), we investigated whether FASN mRNA expression (assessed by PCR) in adipose tissue is increased in obesity and related to visceral fat accumulation, measures of insulin sensitivity (euglycaemic-hyperinsulinaemic clamp) and glucose metabolism. RESULTS:FASN mRNA expression was increased by 1.7-fold in visceral vs subcutaneous fat. Visceral adipose tissue FASN expression was correlated with FASN protein levels, subcutaneous FASN expression, visceral fat area, fasting plasma insulin, serum concentrations of IL-6, leptin and retinol-binding protein 4 (RBP4), and inversely with measures of insulin sensitivity, independently of age, sex and BMI. Moreover, we found significant correlations between FASN expression and markers of renal function, including serum creatinine and urinary albumin excretion. CONCLUSIONS/ INTERPRETATION: Increased FASN gene expression in adipose tissue is linked to visceral fat accumulation, impaired insulin sensitivity, increased circulating fasting insulin, IL-6, leptin and RBP4, suggesting an important role of lipogenic pathways in the causal relationship between consequences of excess energy intake and the development of obesity and type 2 diabetes.
Authors: Timothy E Graham; Qin Yang; Matthias Blüher; Ann Hammarstedt; Theodore P Ciaraldi; Robert R Henry; Christopher J Wason; Andreas Oberbach; Per-Anders Jansson; Ulf Smith; Barbara B Kahn Journal: N Engl J Med Date: 2006-06-15 Impact factor: 91.245
Authors: Stanley M Walls; Anthony Cammarato; Dale A Chatfield; Karen Ocorr; Greg L Harris; Rolf Bodmer Journal: Cell Rep Date: 2018-03-06 Impact factor: 9.423
Authors: Jose Manuel Fernandez-Real; Javier A Menendez; Jose Maria Moreno-Navarrete; Matthias Blüher; Alejandro Vazquez-Martin; María Jesús Vázquez; Francisco Ortega; Carlos Diéguez; Gema Frühbeck; Wifredo Ricart; Antonio Vidal-Puig Journal: Diabetes Date: 2010-03-18 Impact factor: 9.461
Authors: María D Mayas; Francisco J Ortega; Manuel Macías-González; Rosa Bernal; Ricardo Gómez-Huelgas; José M Fernández-Real; Francisco J Tinahones Journal: Nutr Metab (Lond) Date: 2010-01-15 Impact factor: 4.169
Authors: Sandeep J Joseph; Kelly R Robbins; Enrique Pavan; Scott L Pratt; Susan K Duckett; Romdhane Rekaya Journal: Bioinform Biol Insights Date: 2010-03-31
Authors: Francesca E Mackenzie; Rosario Romero; Debbie Williams; Thomas Gillingwater; Helen Hilton; Jim Dick; Joanna Riddoch-Contreras; Frances Wong; Lisa Ireson; Nicola Powles-Glover; Genna Riley; Peter Underhill; Tertius Hough; Ruth Arkell; Linda Greensmith; Richard R Ribchester; Gonzalo Blanco Journal: Hum Mol Genet Date: 2009-07-04 Impact factor: 6.150